Medindia

X

New Biomarker for Pregnancy-associated Heart Disease Identified

by Sheela Philomena on  April 26, 2013 at 10:10 AM Women Health News   - G J E 4
University of Liege in Liege, Belgium have discovered miR-146a a new molecule that can serve as a potential biomarker for peripartum cardiomyopathy. Peripartum cardiomyopathy (PPCM) is a deterioration in cardiac function that occurs in pregnant women during the last month or in the months following their pregnancy.
 New Biomarker for Pregnancy-associated Heart Disease Identified
New Biomarker for Pregnancy-associated Heart Disease Identified
Advertisement

Struman and colleagues found that expression of miR-146a was induced by the nursing hormone prolactin. MiR-146a expression promoted vascular damage and was increased in a mouse model of PPCM. Conversely, loss of miR-146a in mice prevented PPCM. Importantly, miR-146a expression was elevated in the serum of pregnant women who developed PPCM, suggesting that serum miR-146a levels could predict which patients are at risk for the disease. In a companion commentary, Richard Kitsis of Albert Einstein College of Medicine in New York, discusses the potential implications of this work for the identification and treatment of PPCM.

Advertisement
Source: Eurekalert
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All